ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

XAIR vs ICCM // EV/EBITDA & P/E VALUATION

Beyond Air Inc. (NASDAQ) VS. IceCure Medical Ltd. (NASDAQ) • 15-METRIC TALLY: XAIR 4 — ICCM 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XAIR VS. ICCM) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC XAIR ICCM SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 3.30% 36.30% -33.00 ICCM /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin 0.40% -60.00% +60.40 XAIR /net-margins <GO>
Revenue Growth (YoY) 107.30% 2.70% +104.60 XAIR /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 5/9 -2.00 ICCM /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 39.7 18.1 +21.59 XAIR /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 94.2x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $3.8M $3.3M $569.3K XAIR /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR XAIR REV ICCM REV XAIR GROSS % ICCM GROSS % XAIR FCF ICCM FCF
FY 2025 $7.7M $3.4M 3.3% 36.3% -$19.2M -$14.6M
FY 2024 $3.7M $3.3M -44.9% 44.1% -$44.1M -$12.6M
FY 2023 $1.2M $3.2M — — -$56.0M -$12.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XAIR // BETA —
ICCM // BETA —